ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
US Tech 100
19,000.00
-0.94%
Dow Jones
40,287.53
-0.93%
Brent Oil
82.305
0.03%
Bitcoin
67,754.68
-0.59%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Neovasc Inc (NVCN)

  7. Neovasc Inc (NVCN) News

NVCN

Neovasc (NVCN)

Neovasc Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NVCN
DateTimeSourceHeadlineSymbolCompany
08/03/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NVCNNeovasc Inc
04/24/20234:15PMEdgar (US Regulatory)Notice of Termination of a Foreign Private Issuer's Registration of a Class of Securities Under Section 12(b) (15f-12b)NASDAQ:NVCNNeovasc Inc
04/12/20231:11PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NVCNNeovasc Inc
04/11/20239:19AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NVCNNeovasc Inc
04/11/20239:11AMEdgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:NVCNNeovasc Inc
04/11/20239:08AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10pos)NASDAQ:NVCNNeovasc Inc
04/11/20239:07AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:NVCNNeovasc Inc
04/11/20239:06AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:NVCNNeovasc Inc
04/11/20238:48AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:NVCNNeovasc Inc
04/11/20238:21AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NVCNNeovasc Inc
04/11/20238:20AMGlobeNewswire Inc.Shockwave Medical Completes Acquisition of NeovascNASDAQ:NVCNNeovasc Inc
03/31/20234:11PMGlobeNewswire Inc.Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:NVCNNeovasc Inc
03/09/20234:26PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NVCNNeovasc Inc
03/07/20236:09AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NVCNNeovasc Inc
03/06/20235:37PMGlobeNewswire Inc.Neovasc Shareholders Approve Acquisition by Shockwave MedicalNASDAQ:NVCNNeovasc Inc
02/10/20234:08PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NVCNNeovasc Inc
02/01/20239:07AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NVCNNeovasc Inc
02/01/20239:05AMGlobeNewswire Inc.Neovasc Announces German Reimbursement RenewalNASDAQ:NVCNNeovasc Inc
01/27/20234:06PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NVCNNeovasc Inc
01/17/20239:29AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NVCNNeovasc Inc
01/17/20238:00AMGlobeNewswire Inc.Shockwave Medical to Acquire NeovascNASDAQ:NVCNNeovasc Inc
01/17/20238:00AMGlobeNewswire Inc.Shockwave Medical Announces Agreement to Acquire NeovascNASDAQ:NVCNNeovasc Inc
11/28/20224:45PMGlobeNewswire Inc.Neovasc Announces Progress on COSIRA-II Clinical TrialNASDAQ:NVCNNeovasc Inc
11/18/20229:07AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NVCNNeovasc Inc
11/18/20229:05AMGlobeNewswire Inc.Neovasc Comments on European Heart Journal PublicationNASDAQ:NVCNNeovasc Inc
11/15/20226:45AMTipRanksH.C. Wainwright Sticks to Its Buy Rating for Neovasc (NVCN)NASDAQ:NVCNNeovasc Inc
11/10/20224:08PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NVCNNeovasc Inc
11/10/20224:05PMGlobeNewswire Inc.Neovasc Announces Third Quarter Financial Results and Provides Corporate UpdateNASDAQ:NVCNNeovasc Inc
11/08/20229:05AMGlobeNewswire Inc.Neovasc Reducer Obtains U.S. Outpatient ReimbursementNASDAQ:NVCNNeovasc Inc
10/27/20229:04AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NVCNNeovasc Inc
 Showing the most relevant articles for your search:NASDAQ:NVCN

Your Recent History

USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
BIEL
Bioelectronics (PK)
USOTC
HIRU
Hiru (PK)
USOTC
SPZI
Spooz (PK)
USOTC
RONN
Ronn Motor (PK)
COIN
BTCUSD
Bitcoin
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
AVXL
Anavex Life Sciences
NASDAQ
COOP
Mr Cooper
USOTC
KEGS
1812 Brewing (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
NASDAQ
AMRN
Amarin
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
NSAV
Net Savings Link (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved